Singapore markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
26.36-1.17 (-4.25%)
At close: 04:00PM EDT
26.50 +0.14 (+0.53%)
Pre-market: 05:35AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 288.31M
Enterprise value 152.45M
Trailing P/E 4.26
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.32
Price/book (mrq)1.37
Enterprise value/revenue 0.14
Enterprise value/EBITDA 1.09

Trading information

Stock price history

Beta (5Y monthly) 1.15
52-week change 3-70.09%
S&P500 52-week change 323.57%
52-week high 3109.52
52-week low 325.92
50-day moving average 335.56
200-day moving average 363.77

Share statistics

Avg vol (3-month) 3436.39k
Avg vol (10-day) 3553.22k
Shares outstanding 510.94M
Implied shares outstanding 610.94M
Float 89.73M
% held by insiders 12.69%
% held by institutions 196.40%
Shares short (15 Apr 2024) 42.99M
Short ratio (15 Apr 2024) 46.79
Short % of float (15 Apr 2024) 441.67%
Short % of shares outstanding (15 Apr 2024) 427.43%
Shares short (prior month 15 Mar 2024) 42.05M

Dividends & splits

Forward annual dividend rate 46.6
Forward annual dividend yield 425.04%
Trailing annual dividend rate 33.30
Trailing annual dividend yield 311.99%
5-year average dividend yield 44.78
Payout ratio 453.31%
Dividend date 307 Nov 2023
Ex-dividend date 418 Sept 2023
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.55%
Operating margin (ttm)5.29%

Management effectiveness

Return on assets (ttm)16.44%
Return on equity (ttm)35.49%

Income statement

Revenue (ttm)897.81M
Revenue per share (ttm)82.40
Quarterly revenue growth (yoy)-49.90%
Gross profit (ttm)N/A
EBITDA 95.53M
Net income avi to common (ttm)67.76M
Diluted EPS (ttm)6.19
Quarterly earnings growth (yoy)-79.20%

Balance sheet

Total cash (mrq)156.43M
Total cash per share (mrq)14.63
Total debt (mrq)20.57M
Total debt/equity (mrq)9.75%
Current ratio (mrq)2.85
Book value per share (mrq)19.73

Cash flow statement

Operating cash flow (ttm)90.88M
Levered free cash flow (ttm)56.58M